Lasya Priya Katukam, Amruta Prabhakar Padakanti, Naveen Chella. Drug Repurposing: History, Significance, Benefits, Approaches, and Challenges.
Ruchira Patil, Harshad Takate, Gaurav Shanbhag, Harshada Kiran S, Amruta Prabhakar Padakanti, Naveen Chella. Clinical Trials on Repurposed Drugs: An Overview.
Prajakta Bule, Tejaswini Kolipaka, Shital Ranvare, Naveen Chella. Redirection to the Drug Discovery: Antidiabetic Drugs Repurposing in Cancer.
Prajakta Bule, Lal Bahadur Pal, Raghunandhan Painoori, Naveen Chella. Intellectual Property Rights and Regulatory Considerations Throughout Drug Repurposing
1. Lalchandani DS, Chenkual L, Sonpasare K, Rajdev B, Naidu V, Chella N, et al. Optimization of atorvastatin and quercetin-loaded solid lipid nanoparticles using Box-Behnken design. Nanomedicine. 2024 Jul 14;19(17):1541–55.
2. Lalchandani DS, Chenkual L, Pate S, Kulhari U, Sahu BD, Chella N, et al. Folic acid-conjugated long circulating co-encapsulated atorvastatin and quercetin solid lipid nanoparticles: pharmacokinetics and biodistribution in rats. Analytical Methods. 2024;
3. Varsa S RB, Priya Katukam L, Kole GK, Dhotre A V., Chella N, Ramanujan GM, et al. Expanding the Crystal Structure Landscape of Pravastatin Complexes: Tuning Solubility, Diffusion, and Pharmacokinetics. Cryst Growth Des. 2024 Jun 19;24(12):5309–23.
4. Vemula SK, Narala S, Uttreja P, Narala N, Daravath B, Chella N, et al. Quality by Design (QbD) Approach to Develop Colon-Specific Ketoprofen Hot-Melt Extruded Pellets: Impact of Eudragit® S 100 Coating on the In Vitro Drug Release. Pharmaceutics. 2024 Sep 27;16(10):1265.
5. Daravath B, Vemula SK, Chella N. Optimizing Nateglinide Liquisolid Compacts: Achieving Formulation Excellence Through the Quality by Design Approach. J Pharm Innov. 2024 Oct 1;19(5):64.
6. Kolimi PR, Padakanti AP, Kolagani N, Ponneganti S, Gangipangi V, Selvaraju S, et al. Polymeric amorphous dispersion as a carrier to enhance the in vitro dissolution in vivo pharmacokinetics and cytotoxicity of niclosamide. Polym Adv Technol. 2023 Aug 22;
7. Arjun S, Kulhari U, Padakanti AP, Sahu BD, Chella N. Colon-targeted delivery of niclosamide from solid dispersion employing a pH-dependent polymer via hotmelt extrusion for the treatment of ulcerative colitis in mice. J Drug Target. 2024 Feb 7;32(2):186–99.
8. Sharma R, Jain H, Pratibha, Godugu C, Chella N. Formulation and optimization of aceclofenac loaded hyaluronic-oleic acid based micellar gel for the management of osteoarthritis. J Drug Deliv Sci Technol. 2023;84.
9. Pal LB, Bule P, Khan W, Chella N. An Overview of the Development and Preclinical Evaluation of Antibody–Drug Conjugates for Non-Oncological Applications. Pharmaceutics. 2023 Jun 24;15(7):1807.
10. Syamprasad NP, Madje N, Bachannagari J, Jannu AK, Jain S, Tene K, et al. Niclosamide nanocrystal for enhanced in-vivo efficacy against gastrointestinal stromal tumor via regulating EGFR/STAT-3/DR-4 axis. J Drug Deliv Sci Technol. 2023;81.
11. Nayakula M, Jeengar MK, Naidu VGM, Chella N. Enhanced Pharmacokinetics and Anti-inflammatory Activity of Curcumin Using Dry Emulsion as Drug Delivery Vehicle. Eur J Drug Metab Pharmacokinet. 2023;48(2):189–99.
12. Padakanti AP, Pawar SD, Kumar P, Chella N. Development and validation of HPLC method for simultaneous estimation of erlotinib and niclosamide from liposomes optimized by screening design. J Liposome Res. 2023;